메뉴 건너뛰기




Volumn 177, Issue 1, 2001, Pages 31-40

A cost analysis of positron emission tomography

Author keywords

[No Author keywords available]

Indexed keywords

RADIOPHARMACEUTICAL AGENT;

EID: 0034979249     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.177.1.1770031     Document Type: Article
Times cited : (36)

References (24)
  • 3
    • 0025009995 scopus 로고
    • Presurgical evaluation for partial epilepsy: Relative contributions of chronic depth-electrode recordings versus FDG-PET and scalp-sphenoidal ictal EEG
    • (1990) Neurology , vol.40 , pp. 1670-1677
    • Engel, J.1    Henry, T.R.2    Risinger, M.W.3
  • 4
    • 0023195431 scopus 로고
    • Positron emission tomography using [18F]fluorodeoxyglucose in brain tumors: A powerful diagnostic and prognostic tool
    • (1987) Invest Radiol , vol.22 , pp. 360-371
    • Di Chiro, G.1
  • 17
    • 0004882478 scopus 로고    scopus 로고
    • Draft guidance for industry on the content and format of new drug applications and abbreviated new drug applications for certain positron emission tomography drug products: Availability
    • (2000) 65 Federal Register , pp. 13010-13011
  • 18
    • 0001049524 scopus 로고    scopus 로고
    • Positron emission tomography drug products: Safety and effectiveness of certain PET drugs for specific indications
    • (2000) 65 Federal Register , pp. 12999-13010
  • 19
    • 85037417576 scopus 로고    scopus 로고
    • Positron emission tomography (PET) scans
    • sec. 50-36, rev. 136, 04/01. Washington, DC: Health and Human Services Department, Health Care Financing Administration
    • (2001) Medicare coverage issues manual


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.